cancer drugs - Michelakis, to mention some details about the suggested dosage,
it would be for possible you, or Dr. Michelakis, to mention some details about the suggested dosage,route of administration, duration,possible adverse effects and the frequency of occurrence. I realise that the product is probably not licensed for general use, so that the responsibility is entirely mine. The reason I am so interested is that my beloved wife Nikky, age 54, was Dxed with endometrial cancer stage 1C in Dec.2007; despite surgery and chemotherapy, she now has lymph-node metastases. I am willing, if permitted to do so, to take her for treatment to the Canadian centers involved in the study, although I am aware that at this stage only patients in the locality are being selected.
their thoughts ? The cost of a cancer drug prescription rose nearly 16% last year, compared with 3% for other prescriptions, says a June report by Express Scripts, a pharmacy benefit manager. The average cost of a 30-day regulation for cancer drugs is now almost $1,600. The report does not include drugs given at a doctor's office, such as Avastin. Barbara Brenner of Breast Cancer Action says she is especially troubled by the cost of Avastin, a newer drug used to treat colorectal cancer that now sells for about $50,000 a year. That price could jump to $100,000 if Avastin is approved to treat breast and lung cancers, because those tumors are treated with higher doses of the medication.
zometa (generic name, zoledronic acid) Click here to learn about classes the brustes cancer drugs . Abraxane (paclitaxel protein-bound particles for injectable suspension) Abraxane was approved by the U.S. Food and Drug Administration in 2005 to help treat women with advanced breast cancer who have not responded well to combination chemotherapy, or who have relapsed within six months of chemotherapy. Abraxane is similar to the drug Taxol but unlike Taxol, is not required to be dissolved in a toxic solvent prior to administration. This solvent can cause allergic reactions in some patients, and to counteract these reactions, patients are often treated with steroids and antihistamines. Patients receiving Abraxane do not need these treatments.
zometa (generic name, zoledronic acid) Click here to learn about classes the brustes cancer drugs . Abraxane (paclitaxel protein-bound particles for injectable suspension) Abraxane was approved by the U.S. Food and Drug Administration in 2005 to help treat women with advanced breast cancer who have not responded well to combination chemotherapy, or who have relapsed within six months of chemotherapy. Abraxane is similar to the drug Taxol but unlike Taxol, is not required to be dissolved in a toxic solvent prior to administration. This solvent can cause allergic reactions in some patients, and to counteract these reactions, patients are often treated with steroids and antihistamines. Patients receiving Abraxane do not need these treatments.